Stay updated on Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Sign up to get notified when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.

Latest updates to the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page
- CheckyesterdayChange DetectedThe NIH announcement about terminology changes from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the study page.SummaryDifference1%

- Check8 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces NIH website updates and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe study record for the Phase 1 BBP-398 and sotorasib trial is now displayed, including its design, eligibility criteria, outcomes, and locations. It states that the study has been terminated for business reasons and is no longer recruiting participants.SummaryDifference64%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0. The page continues to show a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the usual study details, indicating access to the study information is blocked.SummaryDifference19%

Stay in the know with updates to Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C
Enter your email address, and we'll notify you when there's something new on the Argonaut Clinical Trial: BBP-398 & Sotorasib in KRAS-G12C page.